Incretin-Pathway Peptides
Cagrilintide
An acylated amylin analogue supplied as a sealed lyophilized vial for receptor-pharmacology and stability research.
5mg · 10mg · 20mg
View Details
Incretin-Pathway Peptides
A modified GIP-sequence peptide with GLP-1 receptor activity, sealed as a lyophilized vial for receptor research.
Research use only
Tirzepatide is a modified GIP-sequence-based peptide with GLP-1 receptor activity and a lipid-linked side chain, built on the 39-amino-acid class shared with retatrutide. It anchors the incretin-pathway section of this catalog alongside that entry.
This peptide is presented as a research reference for receptor pharmacology, peptide stability studies, and analytical method development. The molecular weight and formula shown on this page describe the peptide as supplied in lyophilized form.
Vials are sealed after freeze-drying and available across the widest size range in this catalog, from 5mg through 100mg. Batch documentation for a specific lot is confirmed by inquiry.
| Purity | ≥99% by HPLC |
|---|---|
| CAS number | 2023788-19-2 |
| Molecular weight | 4813 g/mol |
| Molecular formula | C225H348N48O68 |
| Material class | 39-amino-acid peptide |
| Appearance | White to off-white lyophilized powder |
| Available vial sizes | 5mg · 10mg · 20mg · 30mg · 40mg · 50mg · 60mg · 100mg |
| Documentation | Batch documentation confirmed on request |